Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Hold
688
0.04% 170
2026
Q1
$242K Hold
688
0.04% 139
2025
Q4
$225K Sell
688
-51
-7% -$16.2K 0.04% 146
2025
Q3
$209K Hold
739
0.04% 144
2025
Q2
$206K Hold
739
0.04% 145
2025
Q1
$230K Buy
+739
New +$218K 0.04% 135
2024
Q4
Sell
-739
Closed -$238K 149
2024
Q3
$238K Hold
739
0.04% 136
2024
Q2
$231K Hold
739
0.05% 134
2024
Q1
$210K Hold
739
0.04% 138
2023
Q4
$213K Buy
+739
New +$201K 0.05% 133
2020
Q4
Sell
-805
Closed -$205K 150
2020
Q3
$205K Buy
+805
New +$199K 0.06% 127

Other funds holding AMGN

Peak Asset Management's AMGN Position: Q2 2026 in Review

Peak Asset Management held its Amgen (AMGN) position steady in Q2 2026 at 688 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #170.

Peak Asset Management first reported a position in AMGN in Q3 2020 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Peak Asset Management held 688 shares of Amgen worth $249K as of Q2 2026.
  • Peak Asset Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.04% of Peak Asset Management's portfolio in Q2 2026, its #170 holding.
  • Peak Asset Management first reported a position in Amgen in Q3 2020 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Peak Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.